Whole-exome sequencing reveals novel candidate single nucleotide variations for preventing adverse effects of levonorgestrel implantation

Weiqiang Zhu,Junxian Zhang,Xuelian Yuan,Xiaoli Liu,Zhaofeng Zhang,Yanyan Mao,Ying Feng,Ailing Yue,Junjie Sun,Chuan Wen,Jianhua Xu,Yupei Shen,Yan Che,Jing Du
DOI: https://doi.org/10.2217/pgs-2021-0105
2021-01-01
Pharmacogenomics
Abstract:Aim: To identify novel genes associated with adverse effects of levonorgestrel (LNG) implants based on comparative whole-exome sequencing. Materials & methods: A cohort comprising 104 participants, including 52 controls and 52 women with LNG-related adverse effects, was recruited. Seven cases and eight controls were selected for whole-exome sequencing. We verified 13 single nucleotide variations (SNVs) related with integrin-mediated signaling pathway and cell proliferation using the MassARRAY platform. Results: Finally, we screened 49 cases and 52 controls for analyses. Two SNVs (rs7255721 and rs1042522) were located in ADAMTS10 and TP53, respectively, and significantly different between two groups. These two SNVs lead to changes in protein structure and physicochemical parameters. Conclusion: Here, we defined two pathogenic mutations related to adverse LNG effects.
What problem does this paper attempt to address?